Share this article:

Allergan PLC, which had a rough year following its controversial patent transfer deal with a Native American tribe, said it will cut over 1,000 jobs in preparation for losing patent exclusivity for blockbuster dry-eye drug Restasis...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in Orange County
  • NEW: Orange County 500 — influential business leaders you need to know
Yours for only $99

For digital licensing requests for this article, Contact Kim Lopez